Arrowstreet Capital Limited Partnership bought a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 3,457 shares of the semiconductor company’s stock, valued at approximately $1,678,000.
Other hedge funds also recently made changes to their positions in the company. Kieckhefer Group LLC acquired a new stake in Synopsys in the fourth quarter valued at $27,000. Whipplewood Advisors LLC purchased a new position in shares of Synopsys in the 4th quarter valued at about $33,000. Sierra Ocean LLC acquired a new stake in shares of Synopsys in the fourth quarter valued at about $39,000. Newbridge Financial Services Group Inc. purchased a new stake in Synopsys during the fourth quarter worth about $51,000. Finally, Versant Capital Management Inc grew its position in Synopsys by 109.3% during the fourth quarter. Versant Capital Management Inc now owns 113 shares of the semiconductor company’s stock worth $55,000 after buying an additional 59 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Price Performance
NASDAQ SNPS opened at $406.89 on Friday. The firm has a market capitalization of $62.91 billion, a PE ratio of 28.02, a P/E/G ratio of 3.23 and a beta of 1.23. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $624.80. The company’s 50 day simple moving average is $459.56 and its 200 day simple moving average is $498.75.
Insider Activity at Synopsys
Analysts Set New Price Targets
Several equities analysts recently weighed in on SNPS shares. Morgan Stanley dropped their price objective on Synopsys from $625.00 to $590.00 and set an “overweight” rating for the company in a research note on Monday, February 24th. Needham & Company LLC reissued a “buy” rating and issued a $650.00 price objective on shares of Synopsys in a research note on Thursday, February 27th. Wells Fargo & Company reduced their price target on shares of Synopsys from $540.00 to $520.00 and set an “equal weight” rating on the stock in a report on Thursday, February 27th. Piper Sandler dropped their price objective on shares of Synopsys from $655.00 to $653.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Finally, Redburn Atlantic assumed coverage on Synopsys in a research report on Monday, January 13th. They set a “buy” rating and a $600.00 price objective for the company. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, Synopsys has a consensus rating of “Moderate Buy” and an average price target of $638.58.
Get Our Latest Stock Analysis on SNPS
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Airline Stocks – Top Airline Stocks to Buy Now
- Joby Aviation: Operational Momentum vs. Market Sentiment
- Find and Profitably Trade Stocks at 52-Week Lows
- Broadcom’s Big Outperformance Shows Strength Amid Tariff Decline
- How to trade penny stocks: A step-by-step guide
- Carvana: Can Turnaround Strength Outdrive Market Headwinds?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.